Literature DB >> 10581658

An investigation of factors limiting aerobic capacity in patients with ankylosing spondylitis.

R Carter1, P Riantawan, S W Banham, R D Sturrock.   

Abstract

Ankylosing spondylitis (AS) has been shown to produce exercise limitation and breathlessness. The purpose of this study was to investigate factors which may be responsible for limiting aerobic capacity in patients with AS. Twenty patients with no other cardio-respiratory disease performed integrative cardiopulmonary exercise testing (CPET). The results were compared to 20 age and gender matched healthy controls. Variables that might influence exercise tolerance, including pulmonary function tests (body plethysmography), respiratory muscle strength (MIP, MEP) and endurance (Tlim), AS severity assessment including chest expansion (CE), thoracolumber movement (TL), wall tragus distance and peripheral muscle strength assessed by maximum voluntary contraction of the knee extensors (Qds), hand grip strength and lean body mass (LBM), were measured in the patients with AS and used as explanatory variables against the peak VO2 achieved during CPET. As subjects achieved a lower peak VO2 than controls (25.2 +/- 1.4 vs. 33.1 +/- 1.6 ml kg-1min-1, mean +/- SEM, P = 0.001). When compared with controls, ventilatory response (VE/VCO2) in AS was elevated (P = 0.01); however gas exchange indices, transcutaneous blood gases and breathing reserve were similar to controls. AS subjects developed a higher HR/VO2 response (P < 0.01) on exertion but without associated abnormalities in ECG, blood pressure response or anaerobic threshold. The AS group experienced a greater degree of leg fatigue (P < 0.01) than controls at peak exercise. Although the breathlessness scores (BS) were comparable to controls at peak exercise, the slopes of the relationship between BS and work rate (WR) [AS 0.054 (0.1), Controls 0.043 (0.06); P < 0.05] and BS and % predicted oxygen uptake [AS 0.084 (0.18), Controls 0.045 (0.06); P < 0.01] were steeper in the AS subjects. There was weak association between peak VO2 and vital capacity (r2% 12.0), MIP (11.8) but no association between Tlim, CE, Wall tragus distance or TL movement. The strongest association with aerobic capacity was between measurements of peripheral muscle strength (Qds; r = 0.75; hand grip; r = 0.47) accounting for 53% (P < 0.001) and 23.5% (P < 0.01) of the total variance in peak VO2, respectively. The addition of LBM to Qds in the regression model significantly improved the explained variance to 78.3% (P < 0.001). This study shows that peripheral muscle function is the most important determinant of exercise intolerance in AS patients suggesting that deconditioning is the main factor in the production of the reduced aerobic capacity.

Entities:  

Mesh:

Year:  1999        PMID: 10581658     DOI: 10.1016/s0954-6111(99)90036-7

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  10 in total

1.  Pulmonary involvement in ankylosing spondylitis.

Authors:  Percival D Sampaio-Barros; Elza Maria F P Cerqueira; Sílvio M Rezende; Lucimara Maeda; Roseneide A Conde; Verônica A Zanardi; Manoel Barros Bértolo; José Ribeiro de Menezes Neto; Adil M Samara
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

2.  Pulmonary function in ankylosing spondylitis: association with clinical variables.

Authors:  A J L Brambila-Tapia; A D Rocha-Muñoz; L Gonzalez-Lopez; M Vázquez-Del-Mercado; M Salazar-Páramo; I P Dávalos-Rodríguez; L De la Cerda-Trujillo; M L Diaz-Toscano; P Hernandez-Cuervo; V Diaz-Rizo; D Sanchez-Mosco; J C Vazquez-Jimenez; E G Cardona-Muñoz; J I Gamez-Nava
Journal:  Rheumatol Int       Date:  2013-03-30       Impact factor: 2.631

3.  High disease activity is related to low levels of physical activity in patients with ankylosing spondylitis.

Authors:  Camilla Fongen; Silje Halvorsen; Hanne Dagfinrud
Journal:  Clin Rheumatol       Date:  2013-07-31       Impact factor: 2.980

4.  Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis.

Authors:  Ayla Çağliyan Türk; Sertaç Arslan; Yusuf Karavelioğlu; Macit Kalcik; Sumru Özel; Ahmet Musmul; Füsun Şahin
Journal:  Arch Rheumatol       Date:  2019-04-22       Impact factor: 1.472

5.  [A comparison of respiratory muscle strength, pulmonary function tests and endurance in patients with early and late stage ankylosing spodylitis].

Authors:  G Sahin; H Guler; M Calikoglu; M Sezgin
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

6.  Decreased physical activity and cardiorespiratory fitness in adults with ankylosing spondylitis: a cross-sectional controlled study.

Authors:  Tom O'Dwyer; Finbar O'Shea; Fiona Wilson
Journal:  Rheumatol Int       Date:  2015-08-09       Impact factor: 2.631

7.  Respiratory muscle strength but not BASFI score relates to diminished chest expansion in ankylosing spondylitis.

Authors:  Günşah Sahin; Mukadder Calikoğlu; Cengiz Ozge; Nurgul Incel; Ali Biçer; Bahar Ulşubaş; Hayal Güler
Journal:  Clin Rheumatol       Date:  2004-03-16       Impact factor: 2.980

8.  Combined home exercise is more effective than range-of-motion home exercise in patients with ankylosing spondylitis: a randomized controlled trial.

Authors:  Lin-Fen Hsieh; Chih-Cheng Chuang; Ching-Shiang Tseng; James Cheng-Chung Wei; Wei-Chun Hsu; Yi-Jia Lin
Journal:  Biomed Res Int       Date:  2014-09-07       Impact factor: 3.411

Review 9.  Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature.

Authors:  Juan Carlos Torre-Alonso; Rubén Queiro; Marta Comellas; Luís Lizán; Carles Blanch
Journal:  Patient Prefer Adherence       Date:  2018-05-08       Impact factor: 2.711

Review 10.  Muscle Evaluation in Axial Spondyloarthritis-The Evidence for Sarcopenia.

Authors:  Ana Valido; Carolina Lage Crespo; Fernando M Pimentel-Santos
Journal:  Front Med (Lausanne)       Date:  2019-10-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.